tiprankstipranks

Rodney Lappe Insider Profile

11 Followers
Rodney Lappe, Director, Ten Percent Owner at Mirati Therapeutics, holds 133.02K shares in Design Therapeutics (Ticker: DSGN), holds 1.98M shares in Mirati Therapeutics (Ticker: MRTX). Most recently, Rodney Lappe Bought ― shares of Design Therapeutics on Oct 02, 2023 for an estimated value of 49.14K.
tipranks
Rodney Lappe

Rodney Lappe
Mirati Therapeutics (MRTX)
Director, Ten Percent Owner

Ranked #68,763 out of 98,624 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-16.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$482K
100.00%
A breakdown of Rodney Lappe's holdings

Insider Roles

Design Therapeutics
(DSGN)
Director
Roles that Rodney Lappe holds in companies

Most Profitable Insider Trade

Stock:
Design Therapeutics
(DSGN)
Rating:Informative Buy
Date:Oct 02, 2023 - Today
Return:+65.70%
The most profitable trade made by Rodney Lappe

Rodney Lappe's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MRTX
Mirati Therapeutics
Jul 12, 2013
Informative Buy
$116.23M
Design Therapeutics
Oct 02, 2023
Director
Informative Buy
49.14K
$481.55K
List of latest transactions for each holding click on a transaction to see Rodney Lappe's performance on stock

Rodney Lappe insider profile FAQ

What is the percentage of profitable transactions made by Rodney Lappe?
The percentage of profitable transactions made by Rodney Lappe is 33%.
    What is the average return per transaction made by Rodney Lappe?
    The average return per transaction made by Rodney Lappe is -16.20%.
      What stocks does Rodney Lappe hold?
      Rodney Lappe holds: MRTX, DSGN stocks.
        What was Rodney Lappe’s latest transaction?
        Rodney Lappe latest transaction was an Informative Buy of $49.14K.
          What was Rodney Lappe's most profitable transaction?
          Rodney Lappe’s most profitable transaction was an Informative Buy of DSGN stock on October 2, 2023. The return on the trade was 65.70%.
            What is Rodney Lappe's role in Mirati Therapeutics?
            Rodney Lappe's role in Mirati Therapeutics is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.